Management of Carotid Disease and Atrial Fibrillation

Anticoagulation Therapy

Single antiplatelet therapy with aspirin (75-325 mg daily) is recommended after carotid endarterectomy (CEA), with a Class I, Level of Evidence A recommendation, and may be continued indefinitely postoperatively, as supported by the American Heart Association 1, 2, 3
Alternative single antiplatelet options include clopidogrel (75 mg daily) and extended-release dipyridamole plus low-dose aspirin (25 mg and 200 mg twice daily, respectively), with lower-dose aspirin (75-100 mg) preferred over higher doses due to similar efficacy with lower bleeding risk 1, 3, 4, 5
Antiplatelet drugs significantly reduce stroke risk after carotid endarterectomy (OR 0.58; 95% CI 0.34-0.98) 5
Combination therapy with antiplatelet agents increases bleeding risk without clear benefit, according to the American College of Cardiology, and is not recommended for long-term secondary prevention due to increased bleeding risk without additional benefit in patients with CVA secondary to carotid artery occlusion 6, 3

The goal of postoperative care after CEA is to prevent complications and promote optimal recovery, with guidelines supported by the American Heart Association and other authorities 1, 2, 3
Noninvasive imaging of the extracranial carotid arteries is reasonable at 1 month, 6 months, and annually after CEA to assess patency and exclude the development of new or contralateral lesions, with duplex ultrasound recommended within the first month after revascularization 1, 2, 7, 8
Once stability has been established over an extended period, surveillance at longer intervals may be appropriate, and termination of surveillance is reasonable when the patient is no longer a candidate for intervention 1, 2
Once-yearly follow-up to check for cardiovascular risk factors and treatment compliance is recommended 8

Aspirin (81-325 mg daily) is recommended preoperatively and continued indefinitely postoperatively, with the addition of clopidogrel 75 mg the night before surgery to reduce perioperative embolic events, and loading doses at initiation include clopidogrel 300-600 mg and aspirin 160 mg 4, 9
Antihypertensive medications should be continued and optimized preoperatively, according to the American College of Cardiology guidelines, and aggressive treatment of post-CEA hypertension is critical, particularly in recently symptomatic patients undergoing surgery within 7-14 days of symptom onset 4

Carotid revascularization (endarterectomy or stenting) is not recommended for patients with chronic total occlusion of the carotid artery 2
For patients with both carotid disease and atrial fibrillation requiring oral anticoagulation, oral anticoagulation alone (preferably with a direct oral anticoagulant) is recommended over combination therapy with antiplatelet agents when safe from post-operative bleeding risk, and oral anticoagulation can typically be initiated 3-14 days after surgery 6
The American College of Cardiology and European Society of Cardiology recommend dual antiplatelet therapy (DAPT) with aspirin 75-100 mg plus clopidogrel 75 mg daily for 21-30 days after carotid endarterectomy in symptomatic patients, followed by indefinite antiplatelet monotherapy, while for patients with carotid stent, DAPT is recommended for at least 30 days 7, 4, 8